Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR "Proactive" Approach To Seeking Controversial Ingredients Data Urged

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel should be "proactive" in conducting literature searches on controversial cosmetic ingredients up for re-review, CIR Director and Scientific Coordinator Alan Anderson urged during the panel's Sept. 10-11 meeting in Washington, D.C.

You may also be interested in...



Parabens Tentative Amended Final Report Issued By CIR

The Cosmetic Ingredient Review Expert Panel is initiating a 90-day comment period on a tentative amended final safety assessment for parabens, which the panel issued during its Dec. 12-13 meeting in Washington, D.C

Parabens Tentative Amended Final Report Issued By CIR

The Cosmetic Ingredient Review Expert Panel is initiating a 90-day comment period on a tentative amended final safety assessment for parabens, which the panel issued during its Dec. 12-13 meeting in Washington, D.C

Butylparaben Toxicity Testing Recommended By NTP Board

The National Toxicology Program Board of Scientific Counselors recommended that toxicity testing be conducted on butylparaben due to the cosmetic preservative's widespread exposure to humans through personal care products, foods and pharmaceuticals

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009620

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel